NovioSense's artist conception of its device in use.
November 20, 2018
Last week, Alphabet subsidiary Verily Life Sciences announced the end, at least for the foreseeable future, of its glucose-sensing contact lens collaboration with Novartis.
Verily CTO Brian Otis gave his thoughts in a blog post at the time, stressing the learnings the company got from the project. In a recent interview with MobiHealthNews, Novartis Global Head of Digital Development Jacob LaPorte...
June 1, 2016
Medella Health, the company whose founding team includes a Thiel Fellow and is racing Google and Novartis to develop a glucose-sensing contact lens, has raised $1.4 million in funding. Backers include 1517 Fund, Fifty Years Fund, Garage Capital, BDC Capital and others.
Not too much is known yet about Medella's lens. The company says it will integrate a small sensor, a chip, and a micro-antenna...
June 8, 2015
Thiel Foundation has announced that Harry Gandhi, cofounder and CEO of digital health startup Medella Health will be a 2015 Thiel Fellow. Medella Health is developing glucose-sensing contact lenses.
This year's group of 20 Thiel Fellows were selected from 2,800 applicants. Fellows receive $100,000 and mentorship from the Foundation’s network of founders, investors, and scientists. They can...